Peptide record

TPDB01251

ACE inhibitor from beta-Lg (fr. 7-9) – Wheylin-2 ACE inhibitors Antihypertensive Antioxidant Neuropeptide standard
3 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB01251
ACE inhibitor from beta-Lg (fr. 7-9) – Wheylin-2
ACE inhibitors Antihypertensive Antioxidant Neuropeptide
Cardiometabolic peptides Neuroactive peptides Functional / health-promoting peptides
Peptipedia AHTPDB AHTpin AnOxPePred - 1.0 AODB Multi-AOP
standard
No
A 3-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, Antioxidant, and other sources) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
MKG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C13H26N4O4S1
ARNDCEQHILFPSTWYV
GKM
334.43
10.10
1
0
1
+1
0.75
-0.800
0.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
0
L
1
K
1
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 1 M: 1 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
3 reviewed residue count
C13H26N4O4S1 sequence-only estimate (linear, free termini)
334.43 sequence-only estimate (linear, free termini)
10.10 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.75 sequence-only estimate (linear, free termini)
-0.800 sequence-only estimate (linear, free termini)
334.4350 Activity
334.1669 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
71.85 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Hernández-Ledesma B., Ramos M., Recio I., Amigo L.
Effect of beta-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides. J. Chromatogr. A, 1116, 31-37, 2006
2006
Journal

Other

3
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CCCCN)C(=O)NCC(=O)O InChI=1S/C13H26N4O4S/c1-22-7-5-9(15)12(20)17-10(4-2-3-6-14)13(21)16-8-11(18)19/h9-10H,2-8,14-15H2,1H3,(H,16,21)(H,17,20)(H,18,19)/t9-,10-/m0/s1 InChIKey=AXHNAGAYRGCDLG-UWVGGRQHSA-N Anxiolytic-like peptide according to the BIOPEP-UWM database of bioactive peptides (ID 10112)
Evidence 2 Activity

Activity

IC50
Antihypertensive
71.85 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Hernández-Ledesma B., Ramos M., Recio I., Amigo L.
Effect of beta-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides. J. Chromatogr. A, 1116, 31-37, 2006
2006
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
3
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(CCCCN)C(=O)NCC(=O)O InChI=1S/C13H26N4O4S/c1-22-7-5-9(15)12(20)17-10(4-2-3-6-14)13(21)16-8-11(18)19/h9-10H,2-8,14-15H2,1H3,(H,16,21)(H,17,20)(H,18,19)/t9-,10-/m0/s1 InChIKey=AXHNAGAYRGCDLG-UWVGGRQHSA-N Anxiolytic-like peptide according to the BIOPEP-UWM database of bioactive peptides (ID 10112)
Evidence 3 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

AODB
DFBP
Additional Detail Fields 1 fields
3